| Effects of a standardized extract of Withania somnifera (Ashwagandha) on depression and anxiety symptoms in persons with schizophrenia participating in a randomized, placebo … JM Gannon, J Brar, A Rai, KNR Chengappa Ann Clin Psychiatry 31 (2), 123-129, 2019 | 70 | 2019 |
| Adjunctive Use of a Standardized Extract of Withania somnifera (Ashwagandha) to Treat Symptom Exacerbation in Schizophrenia: A Randomized, Double-Blind … KNR Chengappa, JS Brar, JM Gannon, PJ Schlicht The Journal of Clinical Psychiatry 79 (5), 22496, 2018 | 64 | 2018 |
| Subtle changes in thyroid indices during a placebo-controlled study of an extract of Withania somnifera in persons with bipolar disorder JM Gannon, PE Forrest, KNR Chengappa Journal of Ayurveda and integrative medicine 5 (4), 241, 2014 | 57 | 2014 |
| Treating insulin resistance with metformin as a strategy to improve clinical outcomes in treatment-resistant bipolar depression (the TRIO-BD Study): a randomized, quadruple … CV Calkin, KNR Chengappa, K Cairns, J Cookey, J Gannon, M Alda, ... The Journal of clinical psychiatry 83 (2), 39459, 2022 | 44 | 2022 |
| Reducing anticholinergic medication burden in patients with psychotic or bipolar disorders AM Lupu, K Clinebell, JM Gannon, JC Ellison, KNR Chengappa The Journal of Clinical Psychiatry 78 (9), 17141, 2017 | 44 | 2017 |
| Group teletherapy for first‐episode psychosis: Piloting its integration with coordinated specialty care during the COVID‐19 pandemic HJ Wood, JM Gannon, KNR Chengappa, DK Sarpal Psychology and Psychotherapy: Theory, Research and Practice 94 (2), 382-389, 2021 | 39 | 2021 |
| Long acting injectable antipsychotic medications: ensuring care continuity during the COVID-19 pandemic restrictions JM Gannon, J Conlogue, R Sherwood, J Nichols, JR Ballough, ... Schizophrenia research 222, 532, 2020 | 31 | 2020 |
| Evaluation of branched-narrative virtual patients for interprofessional education of psychiatry residents GL Wilkening, JM Gannon, C Ross, JL Brennan, TJ Fabian, MJ Marcsisin, ... Academic Psychiatry 41, 71-75, 2017 | 30 | 2017 |
| Schizophrenia and related disorders MJ Marcsisin, JB Rosenstock, JM Gannon Oxford University Press, 2016 | 22 | 2016 |
| Less is more: deprescribing anticholinergic medications in persons with severe mental illness AM Lupu, KL MacCamy, JM Gannon, JS Brar, KNR Chengappa Ann Clin Psychiatry 33 (2), 80-92, 2021 | 21 | 2021 |
| Initial cross-over test of a positive allosteric modulator of alpha-7 nicotinic receptors to aid cessation in smokers with or without schizophrenia KA Perkins, KN Roy Chengappa, JL Karelitz, MC Boldry, V Michael, ... Neuropsychopharmacology 43 (6), 1334-1342, 2018 | 21 | 2018 |
| Addressing clozapine under-prescribing and barriers to initiation: a psychiatrist, advanced practice provider, and trainee survey JG Leung, J Cusimano, JM Gannon, O Milgrom, SC Valcourt, JB Stoklosa, ... International Clinical Psychopharmacology 34 (5), 247-256, 2019 | 18 | 2019 |
| Ensuring care for clozapine-treated schizophrenia patients during the COVID-19 pandemic J Nichols, JM Gannon, J Conlogue, D Sarpal, JL Montgomery, ... Schizophrenia Research 222, 499, 2020 | 17 | 2020 |
| Obsessive Compulsive Disorder R Hudak, JM Gannon Handbook of Psychiatric Disorders in Adults in the Primary Care Setting, 119-140, 2022 | 10 | 2022 |
| Racial differences in S100b levels in persons with schizophrenia JM Gannon, DL Kelly, A Besch, T Thakur, N Khurana, MR Shurin, ... Psychiatric Quarterly 91, 137-145, 2020 | 9 | 2020 |
| Sustainability of tribal villages in West Bengal: the impact of technological and environmental change at village level CA Tisdell, KC Roy, J Gannon Economic Development and Change: South Asia and the Third World, Wiley …, 1996 | 8 | 1996 |
| Deprescribing anticholinergic medication in the community mental health setting: a quality improvement initiative JM Gannon, A Lupu, J Brar, M Brandt, S Zawacki, S John, K Carl, ... Research in Social and Administrative Pharmacy 17 (10), 1841-1846, 2021 | 7 | 2021 |
| Long-acting risperidone injections in a pregnant patient with bipolar disorder. K Clinebell, J Gannon, S Debrunner, KN Roy Chengappa Bipolar Disorders 19 (7), 2017 | 7 | 2017 |
| Rapid expansion of direct-to-consumer telemental health during the COVID-19 pandemic: A case series JM Gannon, A Schlesinger, J Glance, M Sujata, N Fredrick, J Wyler, ... Ann Clin Psychiatry 33 (1), 27-34, 2021 | 6 | 2021 |
| From office-based treatment to telehealth: comparing clinical outcomes and patient participation in a psychiatric intensive outpatient program with a large transdiagnostic sample JM Gannon, JS Brar, S Zawacki, T Painter, K O'Toole, KNR Chengappa Telemedicine and e-Health 28 (8), 1126-1133, 2022 | 4 | 2022 |
K N Roy ChengappaProfessor of Psychiatry, University of PittsburghVerified email at upmc.edu
